Brief: Salarius, VolitionRx Enter Into Research, Development Collaboration Deal
02/08/2022 14:24
Aug 2 (Reuters) - Salarius Pharmaceuticals Inc SLRX.O :
* SALARIUS PHARMACEUTICALS AND VOLITIONRX ENTER INTO
RESEARCH AND
DEVELOPMENT COLLABORATION AGREEMENT
Source text for Eikon: ID:nGNX35NCMR
Further company coverage: SLRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on VolitionRX
See all newsBrief: Volitionrx -Files Preliminary Prospectus For 10,006,360 Shares Of Common Stock Offered By Selling Stockholder - SEC Filing
Brief: Volitionrx - Advances Nu.Q Nets Platform Towards Commercialization
Brief: VolitionRX Limited Announces First Quarter 2026 Financial Results
Brief: Volition Reports Breakthrough In Liquid Biopsy Achievement Of Over 99% Purity In Isolating Cancer Dna
Brief: Volition Announces First Ever Automated Nu.Q® Vet Cancer Test With Fujifilm Vet Systems